Clay Siegall Drives Seattle Genetics through Development of ADC Programs.

Dr. Clay B. Siegall co-founded Seattle Genetics, Inc. in 1998, serves as the company’s Board chairman, and Chief Executive Officer. Seattle Genetics focuses on addressing unmet medical needs for cancer patients using antibody-based therapies. Through multiple strategic collaborations with companies in oncology, the company has managed to develop a broad pipeline of product candidates including […]